Seek Returns

ICLR vs. TMO: ICON vs. Thermo Fisher Scientific Stock Comparison

How do ICON (ICLR) and Thermo Fisher Scientific (TMO) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

ICON (ICLR) and Thermo Fisher Scientific (TMO) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Company profile comparison for ICON (ICLR) and Thermo Fisher Scientific (TMO)
Profile ItemICLRTMO
NameICON plcThermo Fisher Scientific Inc.
Country/RegionIrelandUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization15.34 billion USD257.42 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateMay 15, 1998March 17, 1980
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

ICLR
TMO
GSPC
Loading price history…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for ICON (ICLR) and Thermo Fisher Scientific (TMO). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for ICON (ICLR) and Thermo Fisher Scientific (TMO). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for ICON (ICLR) and Thermo Fisher Scientific (TMO)
MetricICLRTMO
Total Return (1Y)30.55%24.62%
Total Return (3Y, Annualized)-6.05%17.34%
Total Return (5Y, Annualized)-5.40%3.11%

Risk Profile

Drawdown History

ICLR
TMO
GSPC
Loading price history…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for ICON (ICLR) and Thermo Fisher Scientific (TMO). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for ICON (ICLR) and Thermo Fisher Scientific (TMO)
MetricICLRTMO
Volatility (1Y, Annualized)68.62%29.96%
Beta (5Y)1.170.83
Max Drawdown (5Y)-76.87%-40.95%
Avg. Volume (3M)943.50K2.10M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ICLR and TMO are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for ICON (ICLR) and Thermo Fisher Scientific (TMO)
MetricICLRTMO
Sharpe Ratio (1Y)0.380.68
Sortino Ratio (1Y)0.521.02

Profitability

ROE (TTM)

Thermo Fisher Scientific (TMO) at 13.38% sits in the top ROE quartile, while ICON (ICLR) at 4.70% is closer to the peer norm — stronger capital efficiency for TMO.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.70%

Max
109.18%
Q3
6.23%
ICLR
4.70%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.38%

Max
109.18%
TMO
13.38%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

For every dollar of sales, both ICON (ICLR) at 5.26% and Thermo Fisher Scientific (TMO) at 14.94% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.26%

Max
18.05%
ICLR
5.26%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

14.94%

Max
18.05%
TMO
14.94%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Thermo Fisher Scientific (TMO) at 20.19% operates in the top operating margin quartile, ahead of ICON (ICLR) at 10.73%, which runs around its industry’s norm.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

10.73%

Max
83.12%
Q3
14.77%
ICLR
10.73%
Median
0.00%
Q1
-78.82%
Min
-207.40%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.19%

Max
83.12%
TMO
20.19%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for ICON (ICLR) and Thermo Fisher Scientific (TMO)
MetricICLRTMO
ROE (TTM)4.70%13.38%
ROA (TTM)0.85%5.19%
Net Margin (TTM)5.26%14.94%
Operating Margin (TTM)10.73%20.19%
Gross Margin (TTM)23.44%41.26%

Growth

Revenue Growth

Both ICON (ICLR) at 0.76% and Thermo Fisher Scientific (TMO) at 3.91% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their Revenue Growth across different time periods.

EPS Growth

Thermo Fisher Scientific (TMO) at 7.32% is around its peer norm for EPS growth, while ICON (ICLR) at -71.56% drops into the bottom quartile, signaling weaker earnings momentum.

Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for ICON (ICLR) and Thermo Fisher Scientific (TMO)
MetricICLRTMO
Revenue Growth (YoY)0.76%3.91%
Revenue Growth (3Y CAGR)2.15%-0.27%
EPS Growth (YoY)-71.56%7.32%
EPS Growth (3Y CAGR)-23.82%0.21%

Financial Strength

Current Ratio (MRQ)

Both ICON (ICLR) at 1.32 and Thermo Fisher Scientific (TMO) at 1.81 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.32

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ICLR
1.32
Min
0.10

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.81

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
TMO
1.81
Min
0.10
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

ICON (ICLR) at 0.38 carries an industry-typical debt-to-equity mix, while Thermo Fisher Scientific (TMO) at 0.75 uses more debt funding than most peers.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.38

Max
1.42
Q3
0.65
ICLR
0.38
Median
0.15
Q1
0.02
Min
0.00

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.75

Max
1.42
TMO
0.75
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for ICON (ICLR) and Thermo Fisher Scientific (TMO)
MetricICLRTMO
Current Ratio (MRQ)1.321.81
Debt / Equity (MRQ)0.380.75
Net Debt / EBITDA5.552.91

Dividends

Dividend Yield (TTM)

ICON (ICLR) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Thermo Fisher Scientific (TMO) reports a yield of 0.27%, ranking against industry peers normally.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ICLR
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.27%

TMO
0.27%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

ICON (ICLR) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Thermo Fisher Scientific (TMO) reports a payout of 9.70%, ranking against industry peers normally.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ICLR
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.70%

TMO
9.70%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for ICON (ICLR) and Thermo Fisher Scientific (TMO)
MetricICLRTMO
Dividend Yield (TTM)0.00%0.27%
Dividend Payout Ratio (TTM)0.00%9.70%

Valuation

P/E Ratio (TTM)

Thermo Fisher Scientific (TMO) at 36.64 is near its industry’s usual P/E ratio, while ICON (ICLR) at 81.90 sits in the richer quartile — ICLR needs stronger growth or earnings quality to justify the premium.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

81.90

Max
85.34
ICLR
81.90
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

36.64

Max
85.34
Q3
43.46
TMO
36.64
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

ICON (ICLR) at 1.86 sits in the cheaper P/S ratio quartile while Thermo Fisher Scientific (TMO) at 5.44 prices around its industry’s middle — ICLR costs less per dollar of sales, though read it alongside growth and margins.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.86

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
ICLR
1.86
Min
0.01

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.44

Max
58.18
Q3
25.77
Median
7.30
TMO
5.44
Q1
3.01
Min
0.01
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

ICON (ICLR) at 1.68 sits in the lower P/B ratio quartile against book while Thermo Fisher Scientific (TMO) at 4.70 is valued near its industry’s middle — ICLR is cheaper on assets, though weigh it against ROE and asset quality.

ICLR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.68

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
ICLR
1.68
Min
-5.59

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.70

Max
13.53
Q3
6.54
TMO
4.70
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
ICON (ICLR) vs. Thermo Fisher Scientific (TMO): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for ICON (ICLR) and Thermo Fisher Scientific (TMO)
MetricICLRTMO
P/E Ratio (TTM)81.9036.64
P/S Ratio (TTM)1.865.44
P/B Ratio (MRQ)1.684.70
Free Cash Flow Yield (TTM)3.51%2.50%